Fig. 2: Kaplan–Meier survival analysis in the TCGA cohort. | Cell Death & Disease

Fig. 2: Kaplan–Meier survival analysis in the TCGA cohort.

From: The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents

Fig. 2

A PFI and B OS based on BCL2 mRNA-expression in 471 BC patients treated with chemotherapy other than MTA. C DFI and D PFI based on MCL1 mRNA-expression in 112 BC patients treated with MTA chemotherapy. E PFI and F OS based on NOXA mRNA-expression in 112 BC patients treated with MTA chemotherapy.

Back to article page